One of the most researched equine gastric supplements has been reformulated with a higher quality beta glucan.
Excerpt: LSU White Paper
The following excerpt from the white paper, “Effects of Relyne GI with Beta Glucan (TBG-136™) on stomach health,” demonstrates why horse owners are excited about the new Relyne GI.
Non-glandular (NG) EGUS and severity gastric ulcer scores were significantly lower in the Relyne GI supplement treated group on days 28 and 35, compared to controls.
It’s also important to note that the reformulated RelyneGI was readily consumed by the horses and no adverse clinical signs were seen. Gastric Juice pH also remained low, and horses maintained their body weight.
- The supplement, Relyne GI, Resulted in significant improvement in Non-Glandular stomach health by day 28 and 35.
New Formulation Relyne vs. Placebo
Equine Gastric Ulcer Success Rate
Relyne
Placebo
*Placebo is an inactive substance that looks and tastes like the product being tested but has no effect, also known as a “dummy product".
Citation: Study 1 (Effects of Relyne GI with Beta Glucan (TBG-136) on health stomach, white paper, LSU does not endorse any products for horses.)
relyneGI® Supporting Evidence
Click on the links below to learn more about the supporting evidence on the effects of Relyne GI with Beta Glucan (TBG 136TM) on Stomach health:
- Effects of RelyneGI® with Beta Glucan (TBG 136TM) on Stomach Health
- Polysaccharide treatment reduces gastric ulceration in active horses
- TBG-136, a Schizophyllum commune-derived β-glucan benefits gut microbiota and intestinal health: A randomized, double-blind, and placebo-controlled clinical trial
- Schizophyllum commune‐derived β-glucan improves intestinal health demonstrating protective efects against constipation and common metabolic disorders
- Synbiotic supplementation with prebiotic Schizophyllum commune derived β-(1,3/1,6)-glucan and probiotic concoction benefits gut microbiota and its associated metabolic activities
by You